Alcañiz-Mesas Ana-Isabel, Ruiz-García María-Victoria, Córcoles-Jiménez María-Pilar, Caballero-García María-José, González Álvarez María Teresa
Unidad de Oncología y Hematología, Hospital General de la Gerencia de Atención Integrada de Albacete, Albacete, Spain; Grupo de investigación NurSearch CLM, Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), Castilla-La Mancha, Spain.
Grupo de investigación NurSearch CLM, Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), Castilla-La Mancha, Spain; Servicio de Urgencias Hospitalarias, Hospital General de la Gerencia de Atención Integrada de Albacete, Albacete, Spain.
Enferm Clin (Engl Ed). 2024 Nov-Dec;34(6):448-457. doi: 10.1016/j.enfcle.2024.11.002. Epub 2024 Nov 9.
To evaluate the effectiveness of implementing the Clinical Best Practice Guideline (BPG) "Assessment and Management of Pain" recommendations for pain control in oncological/oncohaematological hospitalized patients.
Ambispective cohort study.
Adults admitted to oncological unit in Hospital of Albacete.
Implementation of GBP recommendations.
indicators exported from clinical history for evaluation of the BPSO® program. Ethical aspects: anonymous data. Data analysis (SPSS®): Descriptive during periods: baseline (T0 = December 2015); initial (T1 = 2017); consolidation (T2 = 2018-2019); sustainability (T3 = 2021-2022). Measurements of central tendency and dispersion, absolute and relative frequencies. Comparison of proportions (Chi-Square) and averages (Student t-test, ANOVA). Statistical significance: p < 0.05.
Included 572 patients, 61.5% (352) men. Daily intervention of pain detection was performed in 94.6% (538) of patients (20%-T0; 98.3%-T1; 98.4%-T2; 91.2%-T3; p < 0.001), pain assessment using an appropriate scale in 97.6% (558) (0%-T0; 98.3%-T1; 99.2%-T2; 100%-T3; p < 0.001); 93.7% (535) had a care plan for assessment and management of pain (0%-T0; 98.3%-T1; 96.3%-T2; 92.3%-T3; p < 0.001). The percentage of patients who had severe pain (6-10) during the first 24 hours was reduced from T1 to T3 (5.1%-T1; 6.6%-T2; 2.1%-T3; p = 0.145), but throughout hospitalization increased from T1 to T3 (19.2%-T1; 17%-T2; 22.5%-T3; p = 0.21).
Implementation of recommendations has led to a statistically significant improvement over the periods in the study; however, no effectiveness has been shown to reduce pain intensity.
评估实施临床最佳实践指南（BPG）“疼痛评估与管理”建议对肿瘤/肿瘤血液科住院患者疼痛控制的有效性。
双向队列研究。
阿尔巴塞特医院肿瘤科室收治的成年人。
实施GBP建议。
1）人口统计学数据。2）GBP建议的实施情况。3）患者结局：入院后24小时内的疼痛强度及住院期间的最大疼痛强度。工具：数字评分法和视觉模拟评分法。
从临床病历中导出指标以评估BPSO®项目。伦理方面：数据匿名。数据分析（SPSS®）：按时间段进行描述性分析：基线期（T0 = 2015年12月）；初期（T1 = 2017年）；巩固期（T2 = 2018 - 2019年）；可持续性阶段（T3 = 2021 - 2022年）。测量集中趋势和离散程度、绝对频率和相对频率。比较比例（卡方检验）和均值（学生t检验、方差分析）。统计学显著性：p < 0.05。
纳入572例患者，61.5%（352例）为男性。94.6%（538例）的患者进行了每日疼痛检测（T0期为20%；T1期为98.3%；T2期为98.4%；T3期为91.2%；p < 0.001），97.6%（558例）的患者使用了适当的量表进行疼痛评估（T0期为0%；T1期为98.3%；T2期为99.2%；T3期为100%；p < 0.001）；93.7%（535例）的患者有疼痛评估与管理的护理计划（T0期为0%；T1期为98.3%；T2期为96.3%；T3期为92.3%；p < 0.001）。入院后24小时内有严重疼痛（6 - 10分）的患者百分比从T1期到T3期有所降低（T1期为5.1%；T2期为6.6%；T3期为2.1%；p = 0.145），但在整个住院期间从T1期到T3期有所增加（T1期为19.2%；T2期为17%；T3期为22.5%；p = 0.21）。
建议的实施在研究期间带来了具有统计学意义的改善；然而，未显示出降低疼痛强度的有效性。
